2015201420132012201120102009|2008|
 
  2008年度

Shibata H., Yoshioka Y., Ohkawa A., Minowa K., Mukai Y., Abe Y., Taniai M., Nomura T., Kayamuro H., Nabeshi H., Sugita T., Imai S., Nagano K., Yoshikawa T., Fujita T., Nakagawa S., Yamamoto A., Ohta T., Hayakawa T., Mayumi T., Vandeenabeele P., Aggarwal BB., Nakamura T., Yamagata Y., Tsunoda S., Kamada H., Tsutsumi Y.
Creation and X-ray structure analysis of the tumor necrosis factor receptor-1-selective mutant of a tumor necrosis factor-alpha antagonist.
J. Biol. Chem., 283:998-1007, 2008. [PubMed]

Sugita T., Yoshikawa T., Mukai Y., Yamanada N., Imai S., Nagano K., Yoshida Y., Shibata H., Yoshioka Y., Nakagawa S., Kamada H., Tsunoda S., Tsutsumi Y.
Comparative Study of the Protein Transduction Domains-Mediated Molecular Transduction.
Br. J. Pharmacol., 153(6):1143-52, 2008. [PubMed]

Abe Y., Yoshikawa T., Kamada H., Shibata H., Nomura T., Minowa K., Kayamuro H., Katayama K., Miyoshi H., Mukai Y., Yoshioka Y., Nakagawa S., Tsunoda S., Tsutsumi Y.
Simple and highly sensitive assay system for TNFR2-mediated soluble- and transmembrane-TNF activity.
J. Immunol. Methods., 335(1-2):71-8, 2008. [PubMed]

Yoshikawa T., Sugita T., Mukai Y., Yamanada N., Nagano K., Nabeshi H., Yoshioka Y., Nakagawa S., Abe Y., Kamada H., Tsunoda S., Tsutsumi Y.
Organelle-targeted delivery of biological macromolecules using the protein transduction domain: Potential applications for peptide aptamer delivery into the nucleus.
J. Mol. Biol., 380(5):777-782, 2008. [PubMed]

Yoshikawa M., Mukai Y., Okada Y., Yoshioka Y., Tsunoda S., Tsutsumi Y., Okada N., Doi T., Nakagawa S.
Ligand independent assembly of purified soluble human Magic Roundabout (Robo4), a tumor endotherial specific marker.
Protein. Expr. Purif., 61(1):78-82, 2008. [PubMed]

Gao J.Q., Kanagawa N., Xu D.H., Han M., Sugita T., Hatanaka Y., Tani Y., Mizuguchi H., Tsutsumi Y., Mayumi T., Okada N., Nakagawa S.
Combination of two fiber-mutant adenovirus vectors, one encoding the chemokine FKN and another encoding cytokine interleukin 12, elicits notably enhanced anti-tumor responses.
Cancer. Immunol. Immunother., 58:291-299, 2008. [PubMed]

Imai S., Mukai Y., Takeda T., Abe Y., Nagano K., Kamada H., Nakagawa S., Tsunoda S., Tsutsumi Y.
The effect of protein properties on display efficiency using the M13 phage display system.
Pharmazie., 63(10):760-764, 2008. [PubMed]

Shibata H., Yoshioka Y., Ohkawa A., Abe Y., Nomura T., Mukai Y., Nakagawa S., Taniai M., Ohta T., Mayumi T., Kamada H., Tsutsumi Y.
The therapeutic effect of TNFR1-selective antagonistic mutant TNF-α in murine hepatitis models.
Cytokine., 44(2):229-233, 2008. [PubMed]

Takahashi A., Komiya E., Kakutani H., Yoshida T., Fujii M., Horiguchi Y., Mizuguchi H., Tsutsumi Y., Tsunoda S., Koizumi N., Isoda K., Yagi K., Watanabe Y., Kondoh M.
Domain mapping of a claudin-4 modulator, the C-terminal region of C-terminal fragment of clostridium perfringens enterotoxin, by site-directed mutagenesis.
Biochem. Pharm., 75:1639-1648, 2008. [PubMed]

Yoshikawa T., Nabeshi H., Yoshioka Y.
Evaluation of Biological Influence of Nano-materials using Toxicokinetic and Toxicoproteomic Approach.
Yakugaku Zasshi., 128(12):1715-1725, 2008. [PubMed]

Tsunoda S., Tsutsumi Y.
Application of nanomaterials for drug innovation and their risks.
Yakugaku Zasshi., 128(12):1713-1714, 2008. [PubMed]

吉岡靖雄, 吉川友章, 角田慎一
医薬品・香粧品におけるナノマテリアルの安全性評価.
Pharma-VISION 第12号., 14-18, 2008.


Copyright (C) 2009 Osaka Univ. Dept. Toxicology All rights reserved.